Literature DB >> 13790367

Development of increased factor VII activity during the spontaneous coagulation of blood.

C L JOHNSTON, P F HJORT.   

Abstract

Keywords:  BLOOD COAGULATION

Mesh：

Substances：

Year:  1961        PMID： 13790367      PMCID： PMC290782          DOI： 10.1172/JCI104308

Source DB:  PubMed          Journal:  J Clin Invest        ISSN： 0021-9738            Impact factor:   14.808


× No keyword cloud information.
  9 in total

1.  Enzymes and blood clotting. I. Trypsin as an accessory factor.

Authors:  J H FERGUSON; E G WILSON; S G IATRIDIS; H A RIERSON; B R JOHNSTON
Journal:  J Clin Invest       Date:  1960-12       Impact factor: 14.808

2.  Surface activation of plasma clotting: a function of Hageman factor.

Authors:  C L JOHNSTON; J H FERGUSON; F A O'HANLON
Journal:  Proc Soc Exp Biol Med       Date:  1958-10

3.  Studies on the fate of coagulation factors during the clotting of normal and pathological blood.

Authors:  C HOUGIE
Journal:  Thromb Diath Haemorrh       Date:  1959-09-01

4.  The fate of factor VII and Stuart factor during the clotting of normal blood.

Authors:  C L JOHNSTON; J H FERGUSON; F A O'HANLON; W L BLACK
Journal:  Thromb Diath Haemorrh       Date:  1959-06-15

5.  Role of Hageman factor in the initiation of clotting by glass; evidence that glass frees Hageman factor from inhibition.

Authors:  O D RATNOFF; J M ROSENBLUM
Journal:  Am J Med       Date:  1958-08       Impact factor: 4.965

6.  The function factor VII.

Authors:  J F ACKROYD
Journal:  Br J Haematol       Date:  1956-10       Impact factor: 6.998

7.  Primary hemorrhagic diseases.

Authors:  J H FERGUSON; J W FRESH; J H LEWIS; M B ZUCKER
Journal:  J Lab Clin Med       Date:  1957-02

8.  Plasma thromboplastin component (PTC), a hitherto unrecognized blood coagulation factor; case report of PTC deficiency.

Authors:  S G WHITE; P M AGGELER; M B GLENDENING
Journal:  Blood       Date:  1953-02       Impact factor: 22.113

9.  Parahemophilia in three siblings (Owren's disease).

Authors:  B ALEXANDER; R GOLDSTEIN
Journal:  Am J Med       Date:  1952-09       Impact factor: 4.965
  9 in total
  2 in total

1.  Activation of human factor VII in plasma and in purified systems: roles of activated factor IX, kallikrein, and activated factor XII.

Authors:  U Seligsohn; B Osterud; S F Brown; J H Griffin; S I Rapaport
Journal:  J Clin Invest       Date:  1979-10       Impact factor: 14.808

2.  Granulocyte elastase cleaves human high molecular weight kininogen and destroys its clot-promoting activity.

Authors:  J Kleniewski; V Donaldson
Journal:  J Exp Med       Date:  1988-06-01       Impact factor: 14.307
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.